New drug candidate may prevent metastasis
A UCF College of Medicine researcher is developing a new treatment that could slow or even stop cancer cells from spreading.
Jan 16, 2024
0
2
A UCF College of Medicine researcher is developing a new treatment that could slow or even stop cancer cells from spreading.
Jan 16, 2024
0
2
For patients whose breast cancer converted from lymph node-positive to lymph node-negative disease after neoadjuvant chemotherapy, skipping adjuvant regional nodal irradiation (RNI) did not increase the risk of disease recurrence ...
Jan 15, 2024
0
0
For patients undergoing surveillance following diagnosis and treatment of ductal carcinoma in situ (DCIS), very few second breast cancers are detected by clinical breast examination by a physician, according to a study published ...
Jan 12, 2024
0
2
Extracts of a plant used in traditional medicine for centuries have shown anti-proliferative effects against breast cancer in a small early-stage clinical trial.
Jan 11, 2024
0
80
Cedars-Sinai Cancer investigators have analyzed the cells within triple-negative breast cancer tumors before and after radiation therapy with immunotherapy, identifying three patient groups with different responses to the ...
Jan 8, 2024
0
43
Including patients as partners for making decisions about their medical treatments is an important aspect of patient-centered care. A new study from England examined choices that patients with breast cancer make when considering ...
Jan 8, 2024
0
0
At a time when some industries are shying away from and questioning the use of AI in daily work, those in the medical field are leaning into the support the technology can provide to doctors.
Jan 5, 2024
0
1
University of Pennsylvania's Abramson Cancer Center is attempting to address one of the most common challenges cancer patients face: Lack of transportation to critically important appointments. Now in its fifth year, the ...
Jan 5, 2024
0
0
Mutations of the tumor suppressor p53 not only have a growth-promoting effect on the cancer cells themselves, but also influence the cells in the tumor's microenvironment. Scientists at the German Cancer Research Center (DKFZ) ...
Jan 3, 2024
0
45
Last month, the U.S. Food and Drug Administration (FDA) approved the use of the drug capivasertib, in combination with a current cancer treatment called fulvestrant for patients with the most common type of breast cancer, ...
Dec 21, 2023
0
0